Cargando…

Cerebral effects of glucagon‐like peptide‐1 receptor blockade before and after Roux‐en‐Y gastric bypass surgery in obese women: A proof‐of‐concept resting‐state functional MRI study

AIM: To assess the effects of Roux‐en‐Y gastric bypass surgery (RYGB)‐related changes in glucagon‐like peptide‐1 (GLP‐1) on cerebral resting‐state functioning in obese women. MATERIALS AND METHODS: In nine obese females aged 40‐54 years in the fasted state, we studied the effects of RYGB and GLP‐1 o...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Duinkerken, Eelco, Bernardes, Gabriel, van Bloemendaal, Liselotte, Veltman, Dick J., Barkhof, Frederik, Mograbi, Daniel C., Gerdes, Victor E. A., Deacon, Carolyn F., Holst, Jens J., Drent, Madeleine L., Diamant, Michaela, ten Kulve, Jennifer, Ijzerman, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821255/ https://www.ncbi.nlm.nih.gov/pubmed/33084088 http://dx.doi.org/10.1111/dom.14233

Ejemplares similares

Alterations in white matter volume and integrity in obesity and type 2 diabetes
por: van Bloemendaal, Liselotte, et al.
Publicado: (2016)

Cortical and subcortical gray matter structural alterations in normoglycemic obese and type 2 diabetes patients: relationship with adiposity, glucose, and insulin
por: Bernardes, Gabriel, et al.
Publicado: (2018)

Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
por: ten Kulve, Jennifer S., et al.
Publicado: (2015)

Brain reward responses to food stimuli among female monozygotic twins discordant for BMI
por: Doornweerd, Stieneke, et al.
Publicado: (2017)

Effects of Insulin Detemir and NPH Insulin on Body Weight and Appetite-Regulating Brain Regions in Human Type 1 Diabetes: A Randomized Controlled Trial
por: van Golen, Larissa W., et al.
Publicado: (2014)

Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes
por: van Ruiten, Charlotte C, et al.
Publicado: (2022)

The presence of cerebral white matter lesions and lower skin microvascular perfusion predicts lower cognitive performance in type 1 diabetes patients with retinopathy but not in healthy controls—A longitudinal study
por: Emanuel, Anna L., et al.
Publicado: (2019)

Resting-State Brain Networks in Type 1 Diabetic Patients With and Without Microangiopathy and Their Relation to Cognitive Functions and Disease Variables
por: van Duinkerken, Eelco, et al.
Publicado: (2012)

Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients
por: Demuru, Matteo, et al.
Publicado: (2014)

Combination therapy with exenatide decreases the dapagliflozin‐induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial
por: van Ruiten, Charlotte C., et al.
Publicado: (2022)

Effects of the noradrenergic agonist clonidine on temporal and spatial attention
por: Nieuwenhuis, Sander, et al.
Publicado: (2007)

Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy
por: van Duinkerken, Eelco, et al.
Publicado: (2014)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions
por: van Duinkerken, E., et al.
Publicado: (2012)

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass
por: Tharakan, George, et al.
Publicado: (2017)

Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
por: Bertrand, Elodie, et al.
Publicado: (2017)

Chenodeoxycholic acid stimulates glucagon‐like peptide‐1 secretion in patients after Roux‐en‐Y gastric bypass
por: Nielsen, Signe, et al.
Publicado: (2017)

Cerebral Blood Flow and Glucose Metabolism in Appetite-Related Brain Regions in Type 1 Diabetic Patients After Treatment With Insulin Detemir and NPH Insulin: A randomized controlled crossover trial
por: van Golen, Larissa W., et al.
Publicado: (2013)

Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543–1556
por: van Baar, Michaël J.B., et al.
Publicado: (2019)

Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion
por: Wewer Albrechtsen, Nicolai J., et al.
Publicado: (2016)

Retinal blood flow is increased in type 1 diabetes mellitus patients with advanced stages of retinopathy
por: Nguyen, Hoang-Ton, et al.
Publicado: (2016)

Brain Activation in Response to Low-Calorie Food Pictures: An Explorative Analysis of a Randomized Trial With Dapagliflozin and Exenatide
por: van Ruiten, Charlotte C., et al.
Publicado: (2022)

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action
por: Hare, Kristine J., et al.
Publicado: (2010)

Glucagon Receptor Signaling and Glucagon Resistance
por: Janah, Lina, et al.
Publicado: (2019)

Food-Related Brain Activation Measured by fMRI in Adults with Prader–Willi Syndrome
por: van Nieuwpoort, Ingrid Caroline, et al.
Publicado: (2021)

Diabetes Self-Care in Older Adults With Type 1 Diabetes Mellitus: How Does Cognition Influence Self-Management
por: Taboada Gjorup, Ana Lúcia, et al.
Publicado: (2021)

Physical exercise prepartum to support metabolic adaptation in the transition period of dairy cattle: A proof of concept
por: Goselink, Roselinde M. A., et al.
Publicado: (2020)

Functional Brain Connectivity and Neurocognitive Functioning in Patients With Long-Standing Type 1 Diabetes With and Without Microvascular Complications: A Magnetoencephalography Study
por: van Duinkerken, Eelco, et al.
Publicado: (2009)

Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass
por: Shah, Meera, et al.
Publicado: (2014)

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
por: Rauch, Thomas, et al.
Publicado: (2012)

Methods and Guidelines for Measurement of Glucagon in Plasma
por: Holst, Jens J., et al.
Publicado: (2019)

Loss of Inverse Relationship Between Pulsatile Insulin and Glucagon Secretion in Patients With Type 2 Diabetes
por: Menge, Björn A., et al.
Publicado: (2011)

Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
por: Holst, Jens Juul
Publicado: (2022)

Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes
por: Jørgensen, Nils B., et al.
Publicado: (2013)

Attention profile of physically recovered COVID-19 inpatients on the day of discharge
por: do Carmo Filho, Aureo, et al.
Publicado: (2022)

Brain Imaging Studies in Pathological Gambling
por: van Holst, Ruth J., et al.
Publicado: (2010)

Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation
por: Larger, Etienne, et al.
Publicado: (2016)

Posterior cingulate gyri metabolic alterations in HIV-positive patients with and without memory deficits
por: Corrêa, Diogo G., et al.
Publicado: (2020)

Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019)

Acute administration of interleukin‐6 does not increase secretion of glucagon‐like peptide‐1 in mice
por: Christiansen, Charlotte B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9kjhrdj24bt5tu7acmi6c5jhvo